Eugenoplatin targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells
Favorite
Share
More Options
18

Open in WPS to view all 18 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
